{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:19:34Z","timestamp":1778656774542,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Diffuse large B cell lymphoma (DLBCL) can occur at nodal and\/or extra-nodal sites. After the gastrointestinal tract, cutaneous involvement predominates in extra-nodal DLBCL. Skin involvement at presentation can be in the form of plaques, papules, nodules or ulcers. Differentiating primary cutaneous DLBCL from systemic DLBCL with cutaneous involvement is important for appropriate patient management.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We describe here, two interesting cases of skin involvement in DLBCL- one primary cutaneous DLBCL and the other, cutaneous involvement in systemic DLBCL with different clinico-pathological profiles. Though both cases had almost similar morphology of the skin lesions (ulcero-proliferative) at presentation, the disease was confined to the skin in the former, while the latter had involvement of lymph nodes and bone marrow.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Meticulous clinical evaluation, appropriate histopathological and immunohistochemical workup helped in their diagnosis and correct classification of the disease status, guiding the further treatment decisions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s43046-021-00085-1","type":"journal-article","created":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T23:04:25Z","timestamp":1631487865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cutaneous involvement in diffuse large B cell lymphoma at presentation: report of two rare cases and literature review"],"prefix":"10.1186","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0918-522X","authenticated-orcid":false,"given":"Sindhu","family":"Kilaru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumya Surath","family":"Panda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sourav","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debahuti","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manas","family":"Baisakh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spoorthy","family":"Kolluri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suma","family":"Devaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lalatendu","family":"Moharana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghanashyam","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,13]]},"reference":[{"issue":"2","key":"85_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1046\/j.1365-2141.2003.04749.x","volume":"124","author":"MB M\u00f8ller","year":"2004","unstructured":"M\u00f8ller MB, Pedersen NT, Christensen BE. Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation--a population-based study of 1575 cases. Br J Haematol. 2004;124(2):151\u20139. https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04749.x.","journal-title":"Br J Haematol."},{"issue":"suppl 5","key":"85_CR2","doi-asserted-by":"publisher","first-page":"v91","DOI":"10.1093\/annonc\/mdw175","volume":"27","author":"U Vitolo","year":"2016","unstructured":"Vitolo U, Seymour JF, Martelli M, Illerhaus G, Illidge T, Zucca E, et al. Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v91\u2013102. https:\/\/doi.org\/10.1093\/annonc\/mdw175.","journal-title":"Ann Oncol."},{"key":"85_CR3","first-page":"1602","volume":"16","author":"H Shen","year":"2018","unstructured":"Shen H, Wei Z, Zhou D, Zhang Y, Han X, Wang W, et al. Primary extra-nodal diffuse large B-cell lymphoma: a prognostic analysis of 141 patients. Oncol Lett. 2018;16:1602\u201314.","journal-title":"Oncol Lett."},{"issue":"10","key":"85_CR4","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1369\/0022155411417309","volume":"59","author":"SA Al-Humood","year":"2011","unstructured":"Al-Humood SA, Al-Qallaf AS, Alshemmari SH, Francis IM, Junaid TA, Marouf RA, et al. Genotypic and phenotypic differences between nodal and extranodal diffuse large B-Cell lymphomas. J Histochem Cytochem. 2011;59(10):918\u201331. https:\/\/doi.org\/10.1369\/0022155411417309.","journal-title":"J Histochem Cytochem."},{"issue":"6","key":"85_CR5","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00277-010-1124-9","volume":"90","author":"B Yu","year":"2011","unstructured":"Yu B, Zhou X, Li B, Xiao X, Yan S, Shi D. FOXP1 expression and its clinicopathologic significance in nodal and extranodal diffuse large B-cell lymphoma. Ann Hematol. 2011;90(6):701\u20138. https:\/\/doi.org\/10.1007\/s00277-010-1124-9.","journal-title":"Ann Hematol."},{"key":"85_CR6","first-page":"470","volume":"36","author":"JB Lu","year":"2007","unstructured":"Lu JB, Li XQ, Zhang PH, Zhou X, Zhang TM, Li XM, et al. Nodal versus extranodal diffuse large B-cell lymphoma: Comparison of clinicopathologic features, immunophenotype and prognosis. Chin J Pathol. 2007;36:470\u20133.","journal-title":"Chin J Pathol."},{"issue":"3","key":"85_CR7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/ajh.23638","volume":"89","author":"JJ Castillo","year":"2014","unstructured":"Castillo JJ, Winer ES, Olszewski AJ. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the surveillance, epidemiology and end results database. Am J Hematol. 2014;89(3):310\u20134. https:\/\/doi.org\/10.1002\/ajh.23638.","journal-title":"Am J Hematol."},{"issue":"17","key":"85_CR8","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1002\/cncr.27381","volume":"118","author":"H Takahashi","year":"2012","unstructured":"Takahashi H, Tomita N, Yokoyama M, Tsunoda S, Yano T, Murayama K, et al. Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era. Cancer. 2012;118(17):4166\u201372. https:\/\/doi.org\/10.1002\/cncr.27381.","journal-title":"Cancer."},{"issue":"2","key":"85_CR9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4103\/ijd.IJD_74_17","volume":"62","author":"RL Selva","year":"2017","unstructured":"Selva RL, Violetti SA, Delfino C, Grandi V, Cicchelli S, Tomasini C, et al. A literature revision in primary cutaneous B-cell lymphoma. Indian J Dermatol. 2017;62(2):146. https:\/\/doi.org\/10.4103\/ijd.IJD_74_17.","journal-title":"Indian J Dermatol."},{"issue":"12","key":"85_CR10","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","volume":"25","author":"NJ Senff","year":"2007","unstructured":"Senff NJ, Hoefnagel JJ, Jansen PM, Vermeer MH, van Baarlen J, Blokx WA, et al. Reclassification of 300 primary cutaneous B-cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. J Clin Oncol. 2007;25(12):1581\u20137. https:\/\/doi.org\/10.1200\/JCO.2006.09.6396.","journal-title":"J Clin Oncol."},{"issue":"16","key":"85_CR11","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","volume":"133","author":"R Willemze","year":"2019","unstructured":"Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703\u201314. https:\/\/doi.org\/10.1182\/blood-2018-11-881268.","journal-title":"Blood."},{"key":"85_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2021.01.006","volume":"111","author":"M Lucioni","year":"2021","unstructured":"Lucioni M, Pescia C, Bonometti A, Fraticelli S, Moltrasio C, Ramponi A, et al. Double expressor and double\/triple hit status among primary cutaneous diffuse large B-cell lymphoma: a comparison between leg type and not otherwise specified subtypes. Hum Pathol. 2021;111:1\u20139. https:\/\/doi.org\/10.1016\/j.humpath.2021.01.006.","journal-title":"Hum Pathol."},{"key":"85_CR13","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.3389\/fonc.2020.01296","volume":"10","author":"I Russo","year":"2020","unstructured":"Russo I, Fagotto L, Sernicola A, Alaibac M. Primary cutaneous B-cell lymphomas in patients with impaired immunity. Front Oncol. 2020;10:1296. https:\/\/doi.org\/10.3389\/fonc.2020.01296.","journal-title":"Front Oncol."},{"issue":"3","key":"85_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/ddg.13773","volume":"17","author":"M Felcht","year":"2019","unstructured":"Felcht M, Klemke C, Nicolay JP, Weiss C, Assaf C, Wobser M, et al. Primary cutaneous diffuse large B-cell lymphoma, NOS and leg type: clinical, morphologic and prognostic differences. J Dtsch Dermatol Ges. 2019;17(3):275\u201385. https:\/\/doi.org\/10.1111\/ddg.13773.","journal-title":"J Dtsch Dermatol Ges."},{"issue":"10","key":"85_CR15","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1002\/cam4.865","volume":"5","author":"M Lucioni","year":"2016","unstructured":"Lucioni M, Berti E, Arcaini L, Croci GA, Maffi A, Klersy C, et al. Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: comparison with current classification and definition of prognostic markers. Cancer Med. 2016;5(10):2740\u201355. https:\/\/doi.org\/10.1002\/cam4.865.","journal-title":"Cancer Med."},{"issue":"1","key":"85_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275\u201382. https:\/\/doi.org\/10.1182\/blood-2003-05-1545.","journal-title":"Blood."},{"issue":"1","key":"85_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1515\/med-2020-0018","volume":"15","author":"A Sica","year":"2020","unstructured":"Sica A, Vitiello P, Caccavale S, Sagnelli C, Calogero A, Doraro CA, et al. Primary cutaneous DLBCL non-GCB type: challenges of a rare case. Open Med. 2020;15(1):119\u201325. https:\/\/doi.org\/10.1515\/med-2020-0018.","journal-title":"Open Med."},{"issue":"2","key":"85_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2340\/00015555-2139","volume":"96","author":"W Lee","year":"2016","unstructured":"Lee W, Won K, Won C, Chang S, Choi J, Moon K, et al. Secondary cutaneous diffuse large B-cell lymphoma has a higher international prognostic index score and worse prognosis than diffuse large B-cell lymphoma. Leg Type. Acta Derm Venereol. 2016;96(2):245\u201350. https:\/\/doi.org\/10.2340\/00015555-2139.","journal-title":"Leg Type. Acta Derm Venereol."},{"issue":"4","key":"85_CR19","doi-asserted-by":"publisher","first-page":"234","DOI":"10.4103\/idoj.IDOJ_8_18","volume":"9","author":"D Chatterjee","year":"2018","unstructured":"Chatterjee D, Bhattacharjee R. Immunohistochemistry in dermatopathology and its relevance in clinical practice. Indian Dermatol Online J. 2018;9(4):234\u201344. https:\/\/doi.org\/10.4103\/idoj.IDOJ_8_18.","journal-title":"Indian Dermatol Online J."},{"issue":"9","key":"85_CR20","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","volume":"24","author":"PL Zinzani","year":"2006","unstructured":"Zinzani PL, Quaglino P, Pimpinelli N, Berti E, Baliva G, Rupoli S, et al. Prognostic factors in primary cutaneous B-cell lymphoma: The Italian Study Group for Cutaneous Lymphomas. J Clin Oncol. 2006;24(9):1376\u201382. https:\/\/doi.org\/10.1200\/JCO.2005.03.6285.","journal-title":"J Clin Oncol."},{"issue":"12","key":"85_CR21","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1200\/JCO.2005.07.155","volume":"23","author":"A L\u00f3pez-Guillermo","year":"2005","unstructured":"L\u00f3pez-Guillermo A, Colomo L, Jim\u00e9nez M, Bosch F, Villamor N, Arenillas L, et al. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23(12):2797\u2013804. https:\/\/doi.org\/10.1200\/JCO.2005.07.155.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"issue":"2","key":"85_CR22","doi-asserted-by":"publisher","first-page":"929","DOI":"10.7314\/APJCP.2013.14.2.929","volume":"14","author":"D Zhou","year":"2013","unstructured":"Zhou D, Xie W-Z, Hu K-Y, Huang W-J, Wei G-Q, He J-S, et al. Prognostic values of various clinical factors and genetic subtypes for diffuse large B-cell lymphoma Patients: a retrospective analysis of 227 cases. Asian Pac J Cancer Prev. 2013;14(2):929\u201334. https:\/\/doi.org\/10.7314\/APJCP.2013.14.2.929.","journal-title":"Asian Pac J Cancer Prev."}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-021-00085-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-021-00085-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-021-00085-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T23:07:29Z","timestamp":1631488049000},"score":1,"resource":{"primary":{"URL":"https:\/\/jenci.springeropen.com\/articles\/10.1186\/s43046-021-00085-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["85"],"URL":"https:\/\/doi.org\/10.1186\/s43046-021-00085-1","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,13]]},"assertion":[{"value":"13 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval has been waived off by the Institutional Ethics Committee (IMS and SUM Hospital, SOA University, Bhubaneswar; dt 8th May 2021) as this is a case report and proper consent for publication from the patient\/relatives was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of clinical details and\/or clinical images was obtained from the patients\u2019 relatives\/next of kin.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}